123 related articles for article (PubMed ID: 1619786)
1. [Attempt to cause hepatitis in duck hepatitis B virus carrier ducks by immunization with DHBV protein].
Kohge N; Fukuda R
Nihon Shokakibyo Gakkai Zasshi; 1992 May; 89(5):1242-51. PubMed ID: 1619786
[TBL] [Abstract][Full Text] [Related]
2. Inflammation of the liver causes mutations in duck hepatitis B virus genome.
Fukuda R; Kohge N; Akagi S; Xuan NT; Tokuda A; Fukumoto S
Gastroenterol Jpn; 1993 Apr; 28(2):254-8. PubMed ID: 7916702
[TBL] [Abstract][Full Text] [Related]
3. Antiviral therapy with entecavir combined with post-exposure "prime-boost" vaccination eliminates duck hepatitis B virus-infected hepatocytes and prevents the development of persistent infection.
Miller DS; Boyle D; Feng F; Reaiche GY; Kotlarski I; Colonno R; Jilbert AR
Virology; 2008 Apr; 373(2):329-41. PubMed ID: 18206204
[TBL] [Abstract][Full Text] [Related]
4. Epitope-specific antibody response to the surface antigen of duck hepatitis B virus in infected ducks.
Cheung RC; Trujillo DE; Robinson WS; Greenberg HB; Marion PL
Virology; 1990 Jun; 176(2):546-52. PubMed ID: 1693247
[TBL] [Abstract][Full Text] [Related]
5. Vaccination of ducks with a whole-cell vaccine expressing duck hepatitis B virus core antigen elicits antiviral immune responses that enable rapid resolution of de novo infection.
Miller DS; Halpern M; Kotlarski I; Jilbert AR
Virology; 2006 May; 348(2):297-308. PubMed ID: 16469347
[TBL] [Abstract][Full Text] [Related]
6. Elimination of immune tolerance to hepatitis virus in an animal model.
Wen YM; Zhang W; Xu YY; Luo YF; Li PY
Chin Med J (Engl); 1992 Mar; 105(3):199-203. PubMed ID: 1395838
[TBL] [Abstract][Full Text] [Related]
7. Covalently closed circular DNA is the predominant form of duck hepatitis B virus DNA that persists following transient infection.
Le Mire MF; Miller DS; Foster WK; Burrell CJ; Jilbert AR
J Virol; 2005 Oct; 79(19):12242-52. PubMed ID: 16160150
[TBL] [Abstract][Full Text] [Related]
8. IFN-gamma increases efficiency of DNA vaccine in protecting ducks against infection.
Long JE; Huang LN; Qin ZQ; Wang WY; Qu D
World J Gastroenterol; 2005 Aug; 11(32):4967-73. PubMed ID: 16124047
[TBL] [Abstract][Full Text] [Related]
9. Duck hepatitis B virus infection and duck hepatocellular carcinoma.
Yang GX; Wang QY; Jin YN; Chi BR; Li JM; Ye WF
Chin Med J (Engl); 1992 Mar; 105(3):217-26. PubMed ID: 1327668
[TBL] [Abstract][Full Text] [Related]
10. Contribution of aflatoxin B1 and hepatitis B virus infection in the induction of liver tumors in ducks.
Cova L; Wild CP; Mehrotra R; Turusov V; Shirai T; Lambert V; Jacquet C; Tomatis L; Trépo C; Montesano R
Cancer Res; 1990 Apr; 50(7):2156-63. PubMed ID: 2107970
[TBL] [Abstract][Full Text] [Related]
11. The development of persistent duck hepatitis B virus infection can be prevented using antiviral therapy combined with DNA or recombinant fowlpoxvirus vaccines.
Feng F; Teoh CQ; Qiao Q; Boyle D; Jilbert AR
Vaccine; 2010 Oct; 28(46):7436-43. PubMed ID: 20833122
[TBL] [Abstract][Full Text] [Related]
12. DNA vaccines expressing the duck hepatitis B virus surface proteins lead to reduced numbers of infected hepatocytes and protect ducks against the development of chronic infection in a virus dose-dependent manner.
Miller DS; Kotlarski I; Jilbert AR
Virology; 2006 Jul; 351(1):159-69. PubMed ID: 16624364
[TBL] [Abstract][Full Text] [Related]
13. Natural duck hepatitis B virus infection in Australia.
Freiman JS; Cossart YE
Aust J Exp Biol Med Sci; 1986 Oct; 64 ( Pt 5)():477-84. PubMed ID: 3579742
[TBL] [Abstract][Full Text] [Related]
14. Electron microscopic studies on duck hepatitis B virus particles in hepatocytes and sequential changes in various patterns of infection.
Okinaga S; Fukuda R; Fukumoto S; Shimada Y
Gastroenterol Jpn; 1991 Aug; 26(4):458-64. PubMed ID: 1916154
[TBL] [Abstract][Full Text] [Related]
15. The sequential change of serum 2',5' oligoadenylate synthetase in different infectious patterns of duck hepatitis B virus in ducks in experimental transmission.
Akagi S; Fukuda R; Shimada Y
Gastroenterol Jpn; 1992 Jun; 27(3):374-81. PubMed ID: 1378031
[TBL] [Abstract][Full Text] [Related]
16. Alteration of infection pattern of duck hepatitis B virus by immunomodulatory drugs.
Fukuda R; Okinaga S; Akagi S; Hidaka M; Ono N; Fukumoto S; Shimada Y
J Med Virol; 1988 Dec; 26(4):387-96. PubMed ID: 3209992
[TBL] [Abstract][Full Text] [Related]
17. Characterization of age- and dose-related outcomes of duck hepatitis B virus infection.
Jilbert AR; Botten JA; Miller DS; Bertram EM; Hall PM; Kotlarski J; Burrell CJ
Virology; 1998 May; 244(2):273-82. PubMed ID: 9601498
[TBL] [Abstract][Full Text] [Related]
18. [Duck hepatitis B virus (DHBV) and viral DNA in duck hepatocellular carcinoma and liver tissue].
Yang GX
Zhonghua Zhong Liu Za Zhi; 1991 Jul; 13(4):249-52. PubMed ID: 1666870
[TBL] [Abstract][Full Text] [Related]
19. [Dynamic detection of duck hepatitis B virus cccDNA in serum of ducks with liver injury].
Zhao KK; Wang Q; Miao XH; Xu WS
Zhonghua Yi Xue Za Zhi; 2010 Sep; 90(35):2509-13. PubMed ID: 21092483
[TBL] [Abstract][Full Text] [Related]
20. Hepatic neoplasms in aflatoxin B1-treated, congenital duck hepatitis B virus-infected, and virus-free pekin ducks.
Cullen JM; Marion PL; Sherman GJ; Hong X; Newbold JE
Cancer Res; 1990 Jul; 50(13):4072-80. PubMed ID: 1972346
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
